StockData
Aptevo Therapeutics Inc. logo

Aptevo Therapeutics Inc. (APVO) stock

APVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.46−0.09 (-15.97%)

Close on Nov 17, 2026Market cap $830.71KP/E –Yield –

Aptevo Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Aptevo Therapeutics's pe ratio was 44.4× on Jul 31, 2023.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jul 31, 202344.4×–

More Aptevo Therapeutics figures

See a number that looks wrong?